PAR1 抗体
(Coagulation Factor II (thrombin) Receptor (F2R))
Coagulation factor II receptor is a 7-transmembrane receptor involved in the regulation of thrombotic response. Proteolytic cleavage leads to the activation of the receptor. F2R is a G-protein coupled receptor family member. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| PAR1 抗体 (AA 251-350) | 人 | 兔 Polyclonal |
|
|
|
| PAR1 抗体 (AA 42-176) | 人 | 小鼠 Monoclonal |
|
|
|
| PAR1 抗体 (N-Term) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| PAR1 抗体 (AA 42-102) | 人 | 小鼠 Monoclonal |
|
|
|
| PAR1 抗体 (Extracellular, N-Term) | 人 | 兔 Polyclonal |
|
|
|
| PAR1 抗体 (AA 42-102) | 人 | 兔 Polyclonal |
|
|
|
| PAR1 抗体 (AA 1-425) | 人 | 小鼠 Polyclonal |
|
|
|
| PAR1 抗体 (Extracellular, N-Term) | 小鼠 | 兔 Polyclonal |
|
|
|
| PAR1 抗体 | 人 | 兔 Polyclonal |
|
|
|
| PAR1 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| PAR1 抗体 (AA 267-316) | 人, 小鼠, 大鼠, Pig, 兔 | 兔 Polyclonal |
|
|
|
| PAR1 抗体 (N-Term) | 人 | 小鼠 Monoclonal |
|
|
|
| PAR1 抗体 (N-Term) | 人, 猴 | 兔 Polyclonal |
|
|
|
| PAR1 抗体 (Internal Region) | 人 | 山羊 Polyclonal |
|
|
|
| PAR1 抗体 (AA 130-425) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| PAR1 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| PAR1 抗体 (Cleaved-Ser42) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| PAR1 抗体 (AA 51-100) | 人, 猴 | 兔 Polyclonal |
|
|
|
| PAR1 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| PAR1 抗体 (AA 42-110) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- SDS (SDS-PAGE: 有验证图片)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
5 references - 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 251-350
Primary Antibody
- ELISA (ELISA: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 5E2E6
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 42-176
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF/ICC (Immunofluorescence (fixed cells): 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- ELISA (ELISA: 有验证图片)
- PLA (Proximity Ligation Assay: 有验证图片)
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2C5
- 标记
- unconjugated
- 抗体亚型
- IgG2b
- 抗原表位
- AA 42-102
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- M (Molecule: 有验证图片)
- ICC (Immunocytochemistry: 有验证图片)
- IF (Immunofluorescence: 所列应用)
- LCI (Live Cell Imaging: 所列应用)
- IC (Immunochromatography: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 61-76, Extracellular, N-Term
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 42-102
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-425
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- M (Molecule: 有验证图片)
- LCI (Live Cell Imaging: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 66-80, Extracellular, N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG1
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 6A7H10
- 标记
- unconjugated
- 抗体亚型
- IgG1
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人, 小鼠, 大鼠, Pig, 兔
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 267-316
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- ATAP2
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- N-Term
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 猴
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 质量等级
- Verified
- 适用
- 人
- 宿主
- 山羊
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Internal Region
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 130-425
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB23879
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 35-63, N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 40-120, Cleaved-Ser42
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 42-110
Latest Publications for our PAR1 抗体
: "Early initiation of a factor Xa inhibitor can attenuate tissue repair and neurorestoration after middle cerebral artery occlusion." in: Brain research, Vol. 1718, pp. 201-211, (2019) (PubMed).
: "Protease-activated receptors are potential regulators in the development of arterial endofibrosis in high-performance athletes." in: Journal of vascular surgery, Vol. 69, Issue 4, pp. 1243-1250, (2019) (PubMed).
: "Interplay of Plasmodium falciparum and thrombin in brain endothelial barrier disruption." in: Scientific reports, Vol. 9, Issue 1, pp. 13142, (2019) (PubMed).
: "Inhibiting trophoblast PAR-1 overexpression suppresses sFlt-1-induced anti-angiogenesis and abnormal vascular remodeling: a possible therapeutic approach for preeclampsia." in: Molecular human reproduction, Vol. 24, Issue 3, pp. 158-169, (2018) (PubMed).
: "Data regarding the effects of thrombin and dabigatran-inhibited thrombin on protease-activated receptor 1 and activation of human atrial fibroblasts." in: Data in brief, Vol. 19, pp. 925-931, (2018) (PubMed).
: "The Thrombin Receptor Restricts Subventricular Zone Neural Stem Cell Expansion and Differentiation." in: Scientific reports, Vol. 8, Issue 1, pp. 9360, (2018) (PubMed).
: "Recovery from trauma induced amnesia correlates with normalization of thrombin activity in the mouse hippocampus." in: PLoS ONE, Vol. 12, Issue 11, pp. e0188524, (2017) (PubMed).
: "Doxycycline directly targets PAR1 to suppress tumor progression." in: Oncotarget, Vol. 8, Issue 10, pp. 16829-16842, (2017) (PubMed).
: "Thrombin-Induced Calpain Activation Promotes Protease-Activated Receptor 1 Internalization." in: International journal of cell biology, Vol. 2017, pp. 1908310, (2017) (PubMed).
: "A fungal protease allergen provokes airway hyper-responsiveness in asthma." in: Nature communications, Vol. 6, pp. 6763, (2016) (PubMed).
: "Protease-activated receptors are potential regulators in the development of arterial endofibrosis in high-performance athletes." in: Journal of vascular surgery, Vol. 69, Issue 4, pp. 1243-1250, (2019) (PubMed).
: "Interplay of Plasmodium falciparum and thrombin in brain endothelial barrier disruption." in: Scientific reports, Vol. 9, Issue 1, pp. 13142, (2019) (PubMed).
: "Inhibiting trophoblast PAR-1 overexpression suppresses sFlt-1-induced anti-angiogenesis and abnormal vascular remodeling: a possible therapeutic approach for preeclampsia." in: Molecular human reproduction, Vol. 24, Issue 3, pp. 158-169, (2018) (PubMed).
: "Data regarding the effects of thrombin and dabigatran-inhibited thrombin on protease-activated receptor 1 and activation of human atrial fibroblasts." in: Data in brief, Vol. 19, pp. 925-931, (2018) (PubMed).
: "The Thrombin Receptor Restricts Subventricular Zone Neural Stem Cell Expansion and Differentiation." in: Scientific reports, Vol. 8, Issue 1, pp. 9360, (2018) (PubMed).
: "Recovery from trauma induced amnesia correlates with normalization of thrombin activity in the mouse hippocampus." in: PLoS ONE, Vol. 12, Issue 11, pp. e0188524, (2017) (PubMed).
: "Doxycycline directly targets PAR1 to suppress tumor progression." in: Oncotarget, Vol. 8, Issue 10, pp. 16829-16842, (2017) (PubMed).
: "Thrombin-Induced Calpain Activation Promotes Protease-Activated Receptor 1 Internalization." in: International journal of cell biology, Vol. 2017, pp. 1908310, (2017) (PubMed).
: "A fungal protease allergen provokes airway hyper-responsiveness in asthma." in: Nature communications, Vol. 6, pp. 6763, (2016) (PubMed).
Aliases for PAR1 抗体
coagulation factor II thrombin receptor (F2R) 抗体coagulation factor II (thrombin) receptor (F2r) 抗体
coagulation factor 2 (thrombin) receptor L homeolog (f2r.L) 抗体
coagulation factor II thrombin receptor (F2r) 抗体
AI482343 抗体
CF2R 抗体
Cf2r 抗体
f2r-a 抗体
HTR 抗体
PAR-1 抗体
Par-1 抗体
PAR1 抗体
Par1 抗体
par1 抗体
ThrR 抗体
TR 抗体
TRGPC 抗体
您还需要查找其他产品吗？
You are here:
